03 Feb 2020 CEPI and GSK announce collaboration to strengthen the global effort to develop a vaccine for the 2019-nCoV virus
02 Feb 2020 Johnson & Johnson Launches Multi-Pronged Response to Coronavirus Global Public Health Threat
02 Feb 2020 CureVac and CEPI extend their Cooperation to Develop a Vaccine against Coronavirus nCoV-2019
02 Feb 2020 Vaxart Announces Initiation of Coronavirus Vaccine Program
02 Feb 2020 Emergent BioSolutions Receives Positive CHMP Opinion for Vaxchora; Anticipates Near-Term Approval by European Medicines Agency
02 Feb 2020 FDA Approves Aimmune’s PALFORZIA™ as First Treatment for Peanut Allergy
30 Jan 2020 Inovio collaborating with Beijing Advaccine to advance INO-4800 vaccine against new coronavirus in China
30 Jan 2020 Tonix Pharmaceuticals Presented Results from a Preclinical Study of TNX-801, a Potential Vaccine to Prevent Smallpox and Monkeypox, in a Poster Presentation at the 2020 American Society for Microbiology (ASM) Biothreats Conference
30 Jan 2020 Geneos Personalized Neoantigen-Targeting Vaccine (GNOS-PV02) to be Utilized in Innovative GT-30 Hepatocellular Carcinoma Trial
28 Jan 2020 Researchers Present Positive Interim Data on Appili Therapeutics’ ATI-1701 Biodefense Program at 2020 ASM Biothreats
28 Jan 2020 Clover Initiates Development of Recombinant Subunit-Trimer Vaccine for Wuhan Coronavirus (2019-nCoV)
28 Jan 2020 GSK licenses tuberculosis vaccine candidate to the Bill & Melinda Gates Medical Research Institute for continued development
27 Jan 2020 GeoVax and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine
23 Jan 2020 Inovio Selected by CEPI to Develop Vaccine Against New Coronavirus
23 Jan 2020 Moderna Announces Funding Award from CEPI to Accelerate Development of Messenger RNA (mRNA) Vaccine Against Novel Coronavirus
23 Jan 2020 CEPI to fund three programmes to develop vaccines against the novel coronavirus, nCoV-2019
21 Jan 2020 Anokion Announces FDA Clearance of IND Application for its Lead Program in Celiac Disease
12 Jan 2020 Positive Final 2-Year Topline Data in Completed DC Vaccine Phase I/II trial in AML Patients
09 Jan 2020 SELLAS Commences Pivotal Phase 3 REGAL Study of Galinpepimut-S (GPS) in Patients with Acute Myeloid Leukemia (AML)
09 Jan 2020 Phase I clinical trial results published for Invectys DNA Vaccine for Cancer using PharmaJet Needle-free injector
07 Jan 2020 Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers
30 Dec 2019 HOOKIPA Announces First Patient Dosed in Phase 1/2 Clinical Trial for HB-201 for the Treatment of Human Papillomavirus 16-Positive Cancers
27 Dec 2019 Sinovac Announces Approval of Varicella Vaccine for Prevention of Varicella-Zoster Virus (Chickenpox) in Children
20 Dec 2019 Vaccitech Oncology Limited Enters Collaboration with Cancer Research UK to Fund a Phase I/IIa Clinical Trial as First-Line NSCLC Therapy
20 Dec 2019 First FDA-approved vaccine for the prevention of Ebola virus disease, marking a critical milestone in public health preparedness and response

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up